Brokerages forecast that Cabot Corporation (NYSE:CBT) will report $0.93 earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Cabot Corporation’s earnings. The lowest EPS estimate is $0.88 and the highest is $0.94. Cabot Corporation reported earnings of $1.00 per share during the same quarter last year, which would suggest a negative year over year growth rate of 7%. The firm is expected to issue its next quarterly earnings report on Monday, October 30th.

According to Zacks, analysts expect that Cabot Corporation will report full-year earnings of $3.45 per share for the current financial year, with EPS estimates ranging from $3.40 to $3.50. For the next fiscal year, analysts anticipate that the company will post earnings of $3.77 per share, with EPS estimates ranging from $3.65 to $4.00. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Cabot Corporation.

Cabot Corporation (NYSE:CBT) last announced its earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.81 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.85 by ($0.04). Cabot Corporation had a return on equity of 16.03% and a net margin of 8.61%. The company had revenue of $705.00 million during the quarter, compared to analysts’ expectations of $664.16 million. During the same quarter last year, the firm posted $0.93 earnings per share. The firm’s revenue was up 13.5% on a year-over-year basis.

Several equities analysts recently weighed in on CBT shares. Aegis reaffirmed a “hold” rating on shares of Cabot Corporation in a research note on Wednesday, May 31st. Zacks Investment Research cut shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. J P Morgan Chase & Co raised shares of Cabot Corporation from a “neutral” rating to an “overweight” rating and set a $57.00 target price for the company in a research note on Tuesday, August 15th. BidaskClub cut shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, ValuEngine cut shares of Cabot Corporation from a “buy” rating to a “hold” rating in a research note on Friday, July 28th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Cabot Corporation currently has a consensus rating of “Buy” and a consensus target price of $60.50.

Shares of Cabot Corporation (NYSE CBT) traded down 0.09% on Friday, reaching $53.30. 342,090 shares of the company traded hands. The firm has a market capitalization of $3.32 billion, a P/E ratio of 14.93 and a beta of 1.09. Cabot Corporation has a 1-year low of $47.99 and a 1-year high of $61.34. The stock has a 50-day moving average price of $52.55 and a 200 day moving average price of $54.85.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 8th. Shareholders of record on Friday, August 25th were paid a $0.315 dividend. The ex-dividend date of this dividend was Wednesday, August 23rd. This represents a $1.26 dividend on an annualized basis and a dividend yield of 2.36%. Cabot Corporation’s payout ratio is currently 35.29%.

COPYRIGHT VIOLATION WARNING: This piece was reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/09/16/cabot-corporation-cbt-expected-to-announce-earnings-of-0-93-per-share.html.

Several large investors have recently modified their holdings of CBT. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Cabot Corporation by 9.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,469 shares of the specialty chemicals company’s stock worth $132,000 after buying an additional 209 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Cabot Corporation by 344.9% in the 1st quarter. Tower Research Capital LLC TRC now owns 2,438 shares of the specialty chemicals company’s stock worth $146,000 after buying an additional 1,890 shares in the last quarter. Old Mutual Global Investors UK Ltd. purchased a new position in shares of Cabot Corporation in the 2nd quarter worth $155,000. Integrated Investment Consultants LLC grew its stake in shares of Cabot Corporation by 66.1% in the 2nd quarter. Integrated Investment Consultants LLC now owns 3,097 shares of the specialty chemicals company’s stock worth $165,000 after buying an additional 1,233 shares in the last quarter. Finally, Meeder Asset Management Inc. grew its stake in shares of Cabot Corporation by 123.1% in the 1st quarter. Meeder Asset Management Inc. now owns 2,892 shares of the specialty chemicals company’s stock worth $173,000 after buying an additional 1,596 shares in the last quarter. 84.29% of the stock is owned by institutional investors and hedge funds.

Cabot Corporation Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through four business segments: reinforcement materials, performance chemicals, purification solutions and specialty fluids. Reinforcement materials’ rubber grade carbon blacks are used to enhance the physical properties of the systems and applications in which they are incorporated.

Get a free copy of the Zacks research report on Cabot Corporation (CBT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Cabot Corporation (NYSE:CBT)

Receive News & Ratings for Cabot Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot Corporation and related companies with MarketBeat.com's FREE daily email newsletter.